Analysis of STAT3 post-translational modifications (PTMs) in human prostate cancer with different Gleason Score.

about

STAT3 and STAT5A are potential therapeutic targets in castration-resistant prostate cancer.

P2860

Q47110097-D28E2A44-0367-428E-8EAB-BB0914877C54

P2860

Analysis of STAT3 post-translational modifications (PTMs) in human prostate cancer with different Gleason Score.

Item

http://www.wikidata.org/entity/Q38794210

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Analysis of STAT3 post-transla ...... with different Gleason Score.

@en

type

Item

label

Analysis of STAT3 post-transla ...... with different Gleason Score.

@en

prefLabel

Analysis of STAT3 post-transla ...... with different Gleason Score.

@en

P1476

Analysis of STAT3 post-transla ...... r with different Gleason Score

@en

P2093

Caterina Grillo

http://www.w3.org/2001/XMLSchema#string

Donatella Romaniello

http://www.w3.org/2001/XMLSchema#string

Fabio Massimo Magliocca

http://www.w3.org/2001/XMLSchema#string

Giacomo Perugia

http://www.w3.org/2001/XMLSchema#string

Giuseppe Borgoni

http://www.w3.org/2001/XMLSchema#string

Ilaria Marrocco

http://www.w3.org/2001/XMLSchema#string

Marcello Liberti

http://www.w3.org/2001/XMLSchema#string

Margherita Eufemi

http://www.w3.org/2001/XMLSchema#string

Rossana Cocchiola

http://www.w3.org/2001/XMLSchema#string

Silvia Chichiarelli

http://www.w3.org/2001/XMLSchema#string

P2860

Structural bases of unphosphorylated STAT1 association and receptor binding

Activation of signal transducer and activator of transcription 3 through a phosphomimetic serine 727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylation

Prostate cancer metastasis: roles of recruitment and reprogramming, cell signal network and three-dimensional growth characteristics

Mechanisms of resistance in castration-resistant prostate cancer (CRPC)

Current clinical challenges in prostate cancer

STAT3 inhibitors for cancer therapy: Have all roads been explored?

Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR

Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation

S-Glutathionylation at Cys328 and Cys542 impairs STAT3 phosphorylation.

STAT3 NH2-terminal acetylation is activated by the hepatic acute-phase response and required for IL-6 induction of angiotensinogen.

P304

42560-42570

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.17245

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Fabio Altieri

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28489571

http://www.w3.org/2001/XMLSchema#string

P932

5522088

http://www.w3.org/2001/XMLSchema#string

Analysis of STAT3 post-translational modifications (PTMs) in human prostate cancer with different Gleason Score.

about

P2860

P2860

Analysis of STAT3 post-translational modifications (PTMs) in human prostate cancer with different Gleason Score.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932